Netflix Nearing Major Deal to Acquire Warner Bros Discovery Assets 
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low 
OpenAI Moves to Acquire Neptune as It Expands AI Training Capabilities 
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative 
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban 
Anthropic Reportedly Taps Wilson Sonsini as It Prepares for a Potential 2026 IPO 
Asian Currencies Steady as Rupee Hits Record Low Amid Fed Rate Cut Bets 
European Oil & Gas Stocks Face 2026 With Cautious Outlook Amid Valuation Pressure 
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies 
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals 
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut 
RBI Cuts Repo Rate to 5.25% as Inflation Cools and Growth Outlook Strengthens 
Visa to Move European Headquarters to London’s Canary Wharf 
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 
Tesla Expands Affordable Model 3 Lineup in Europe to Boost EV Demand 
Asia’s IPO Market Set for Strong Growth as China and India Drive Investor Diversification 
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations 
Johnson & Johnson announced it would stop selling its talc-based baby powder around the world starting next year. The New Jersey-based pharmaceutical industry company further revealed that it would be replacing the discontinued product with cornstarch-based powder.
According to CNN Business, Johnson & Johnson already halted the sale of its talc-based powder in Canada and the United States in 2020 as it has been facing thousands of lawsuits due to claims that its talcum powder caused ovarian cancer in women.
Thousands of women who have developed cancer of the ovary have sued the company. They claimed to have been using the talc-based powder regularly, and the use caused them to be afflicted with the dreaded disease.
In the lawsuits, women alleged that the asbestos in the Johnson & Johnson talcum powder causes cancer. In 2018, the jury in a St. Louis court awarded $4.7 billion to the complainants and their families. The company lost the case when the court said it was negligent and failed to warn consumers about potential health risks from the use of its baby powder.
It was noted that many other talcum powder brands had put warnings on their labels. However, Johnson & Johnson did not, and for this, it argued that such a label would be confusing. Moreover, there were scientific studies that showed an increased risk of ovarian cancer in women who use talc in their genital area, although others do not.
In any case, despite the announcement that it will no longer sell talcum powder, Johnson & Johnson still insisted that its baby powder is safe and does not cause cancer. It stated that it is still confident in the safety of the product but will be pulling them out from the market as part of a "worldwide portfolio assessment."
"We continuously evaluate and optimize our portfolio to best position the business for long-term growth," Johnson & Johnson said in a statement. "This transition will help simplify our product offerings, deliver sustainable innovation, and meet the needs of our consumers, customers and evolving global trends."
The company added, "Our position on the safety of our cosmetic talc remains unchanged and we stand firmly behind the decades of independent scientific analysis by medical experts around the world that confirms talc-based Johnson's Baby Powder is safe, does not contain asbestos, and does not cause cancer."
